Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO plus IPI) in advanced melanoma patients with brain metastases: Real-world evidence from the German non-interventional study NICO

Gutzmer, R. and Eigentler, T. and Mohr, P. and Weichenthal, M. and Duecker, P. and Gebhardt, C. and Goeppner, D. and Haferkamp, S. and Kaehler, K. and Meier, F. and Pfoehler, C. and Satzger, I. and Sickmann, T. and Sindrilaru, A. and Terheyden, P. and Ugurel, S. and Ulrich, J. and Utikal, J. and Weishaupt, C. and Schadendorf, D. (2020) Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO plus IPI) in advanced melanoma patients with brain metastases: Real-world evidence from the German non-interventional study NICO. In: ESMO Virtual Congress, SEP 19-OCT 18, 2020, ELECTR NETWORK.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User: Petra Gürster
Date Deposited: 16 Apr 2021 05:18
Last Modified: 16 Apr 2021 05:18
URI: https://pred.uni-regensburg.de/id/eprint/43892

Actions (login required)

View Item View Item